+34 679 490 537info@nanbiosis.com

Welcome to Nanbiosis – ICTS

NANBIOSIS is one of the 29 ICTS (Singular Scientific Technological Infrastructures) recently recognized by the Spanish Council for Science Policy, Technology and Innovation (MINECO).  NANBIOSIS provides complete services for the production and characterization of nanomaterials, biomaterials and systems in biomedicine. This ICTS is integrated by the Biomedicals Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Jesus Uson Minimally Invasive Surgery Centre (JUMISC).

Platform units

NANBIOSIS is organized in five platforms distributed in Spain: Alava, Badajoz, Barcelona, Cáceres, Madrid, Valencia and Zaragoza. This infrastructure provides high technological resources and high qualified personal, and offers open services to the scientific community.

News

26 Aug

Nanotechnology bio applications in the clinical diagnosis II: biosensor BiMW for the early diagnosis of bacterial infections in cirrhotic patients
Nanotechnology bio applications in the clinical diagnosis II: biosensor BiMW for the early diagnosis of bacterial infections in cirrhotic patients

The peritonitis bacterial spontaneous is an infection of the fluid ascetic that has high incidence in cirrhotic patients and is associated with a high mortality. In such situation, a diagnosis early is essential for the survival of the patient. However, the identification of the causative pathogen of infection is based currently on cultivation methods that [...]

25 Aug

Nanotechnology bio applications in the clinical diagnosis: nanoplasmodic biosensor device for the early diagnosis of colorectal cancer
Nanotechnology bio applications in the clinical diagnosis: nanoplasmodic biosensor device for the early diagnosis of colorectal cancer

The group of Nano-biosensors and Bioanalytical applications of CIBER-BBN which coordinates Unit 4 of NANBIOSIS directed by Dr. Laura Lechuga, has led the final preparations of a technology with potential application in the early diagnosis of colorectal cancer, based in the detection of specific biomarkers in blood. The nanoplasmonic biosensor based on LSPR (Localized Surface [...]

27 Jul

Synergies produced in NANBIOSIS multiply the value of its services and allow its users to have results with faster and superior reliability due to proven experience of the scientists and technicians involved, says Jaume Veciana, Scientific Director of NANBIOSIS, in an interview at July 2016 CIBER-BBN Bulletin.
Synergies produced in NANBIOSIS multiply the value of its services and allow its users to have results with faster and superior reliability due to proven experience of the scientists and technicians involved, says Jaume Veciana, Scientific Director of NANBIOSIS, in an interview at July 2016 CIBER-BBN Bulletin.

In this interview, Jaume Veciana assesses the functioning of this Singular Scientific-Technical Infrastructure and its contribution to research and anticipates some of the guidelines of the NANBIOSIS Strategic Plan 2017-2020, which includes a clear commitment to internationalization. “The scientific-technical capabilities available at NANBIOSIS must be exploited without limitation to our country. Therefore we are clear [...]

About Nanbiosis

units all 1. PLATFORM Biomolecules Production 2. PLATFORM Biomaterials and Nanomaterials Production 3. PLATFORM Tissue, Biomaterial and Surface Characterization 4. PLATFORM Bioimaging 5. PLATFORM High Performance Computing

Nanbiosis: Catalog 2015

The Spanish Strategy for Science, Technology and Innovation 2013-2020, adopted by the Council of Ministers on February 1st, 2013, includes the update of the “National Scientific and Technological Infrastructure Map (ICTS)” for the period 2013-2016 and 2016-2020.

 

The so-called singular scientific and technical infrastructures (ICTS) are large installations, resources, facilities and services, unique in its kind, that are dedicated to cutting edge and high quality research and technological development, as well as to promote exchange, transmission and preservation of knowledge, technology transfer and innovation. These are facilities of different scientific areas ranging from the life sciences to astrophysics or engineering, distributed throughout the Spanish territory.

NANBIOSIS has been recognized by the Spanish Government as one of these 29 UNIQUE existing ICTS, which are OPEN to competitive access to users of the whole research community in the public and private sector.

FAQ

What is NANBIOSIS?

It is one of the 29 UNIQUE ICTS (Singular Scientific Technological Infrastructures) recently recognized by the Spanish Government (MINECO) which is managed by the Biomedicals Research Center in Bioingeneering, Biomaterials and Nanomedicine (CIBER-BBN) and the Center for Minimally Invasive Surgery Jesus Uson (JUMISC).
NANBIOSIS coordinates 27 complementary services under a single contact point model.

Which kind of services offers the platform units?

NANBIOSIS provides a complete service that includes the design and production of biomaterials and nanomaterials and their nanoconjugates, and the characterization of these bio-/nanomaterials, tissues and medicals devices from a physic-chemical, functional, toxicological and biological (including preclinical validation) point of view, focused also on biomedical applications such as: IVDs, biosensors, regenerative medicine, drug delivery, therapeutic agents or MRI contrast agents and medical devices. A Unit dedicated to high performance computing is also included for those technological applications with large scale computational demand.

Who can use these services?

NANABIOSIS is OPEN to users of the whole research community in the public and private sector.
Order request Access protocol

Our figures

0

Units

0

Scientists linked to ICTS

0

Projects since 2008

0

Services since 2008

0

Publications since 2008

0

M€ investment

Nanbiosis